This federal Project Grant award of $435,876.00 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The award, effective March 1, 2025 through February 28, 2027, supports advanced biomedical research by Temple University to investigate KIF11, a novel therapeutic target for lymphedema. The research aims to transform healthcare for military service members, veterans, and the broader public by developing innovative solutions to...
The U.S. Defense Health Agency awarded a $1,999,996 Project Grant to Temple University under the Military Medical Research and Development (CFDA 12.420) program. The grant supports advanced biomedical research to identify diagnostic biomarkers of cerebrovascular contributions to cognitive impairment in repeated blast concussion. This 4-year research project, running from June 2025 to May 2029, aims to transform healthcare for military service members, veterans, and the broader public by...
The federal Project Grant award of $1,585,000.00 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The award, effective March 1, 2025 through February 28, 2029, supports advanced biomedical research at Temple University-Of The Commonwealth System Of Higher Education aimed at "TARGETING LYMPHATIC CHEMOKINE SIGNALING TO PROMOTE LYMPHANGIOGENESIS FOR THE TREATMENT OF LYMPHEDEMA". The grant funding will enable Temple...
Temple University was awarded a $2.53 million Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research into the role of TRAF6 in primary alveolar epithelial cell injury from September 2021 through September 2025. As part of the Military Medical Research and Development program's goals to transform military and public health through innovative medical research, this project will...
The Defense Health Agency awarded a $634,000 Project Grant under the Military Medical Research and Development (CFDA 12.420) federal grant program to Temple University. The grant, titled "Cellular and Molecular Heterogeneity in Esophageal Epithelium as a Contributor to Racial Disparities in Esophageal Cancer," will support research focused on addressing racial disparities in esophageal cancer from September 2024 to September 2026. As a prominent public research university, Temple...
This Project Grant award in the amount of $679,085.00 was issued by the Defense Health Agency, a component of the Department of Defense, under the Military Medical Research and Development program (CFDA 12.420). The funding supports research by Temple University-Of The Commonwealth System Of Higher Education, through its division Temple University, to investigate the role of tumor-associated sensory neurons in breast cancer invasion and metastasis. The award period runs from January 15, 2024...
The U.S. Defense Health Agency awarded a $792,500.00 Project Grant to Temple University-Of The Commonwealth System Of Higher Education, through its division Temple University-Of The Commonwealth System Of Higher Educa and doing business as Temple University, for the purpose of "AN EFFECTIVE STRATEGY TO PROMOTE AXON REGENERATION AND FUNCTIONAL RECOVERY AFTER SPINAL CORD INJURY". The Project Grant is funded through the U.S. Military Medical Research and Development program (CFDA 12.420),...
The Temple University-Of The Commonwealth System Of Higher Education will research novel intracellular oncogenic functions of CTLA4 in melanoma under a $1.19 million Project Grant from the Department of the Army Medical Command. The grant was awarded on August 1, 2022 for a three-year period concluding on July 31, 2025. The research is being conducted under the Military Medical Research and Development program administered by the Department of the Army Medical Command. This program aims to...
Temple University-Of The Commonwealth System Of Higher Education received a $315,618 project grant award from the Defense Health Agency through the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will fund research from June 1, 2023 through May 31, 2025 examining the role of exosomes on the alveolar epithelium in idiopathic pulmonary fibrosis. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research...
This federal Project Grant award of $434,499.00 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant supports research by Temple University-Of The Commonwealth System Of Higher Education to investigate the "RESTORATION OF ALVEOLAR TYPE II CELL FUNCTION IN EMPHYSEMA". The project aims to transform healthcare for military service members, veterans, and the broader public by conducting advanced biomedical research...